HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells

被引：0
|
作者：
J. R. Ribeiro
C. Schorl
N. Yano
N. Romano
K. K. Kim
R. K. Singh
R. G. Moore
机构：
[1] Women and Infants Hospital,Center for Genomics and Proteomics, Genomics Core Facility
[2] Department of Obstetrics and Gynecology,Wilmot Cancer Institute, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology
[3] Program in Women’s Oncology,undefined
[4] Molecular Therapeutics Laboratory,undefined
[5] Brown University,undefined
[6] University of Rochester Medical Center,undefined
来源：
Journal of Ovarian Research | / 9卷
关键词：
HE4; Epithelial ovarian cancer; Chemoresistance; Paclitaxel resistance; Platinum resistance; MAPK signaling; Tubulin; EGR1; SKOV3 cells;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Comparison of two immunoassays for the measurement of serum HE4 for ovarian cancer
    Barr, Chloe E.
    Funston, Garth
    Mounce, Luke T. A.
    Pemberton, Phillip W.
    Howe, Jonathon D.
    Crosbie, Emma J.
    PRACTICAL LABORATORY MEDICINE, 2021, 26
  • [42] Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis
    Anastasi, Emanuela
    Farina, Antonella
    Granato, Teresa
    Colaiacovo, Flavia
    Pucci, Beatrice
    Tartaglione, Sara
    Angeloni, Antonio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (13)
  • [43] Potential role of HE4 in multimodal screening for epithelial ovarian cancer
    Drescher, C. W.
    Urban, N.
    Hartge, P.
    Berg, C. D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 : S44 - S44
  • [44] Is serum HE4 measurement useful in early detection of ovarian cancer?
    Kang, S.
    Hwang, J.
    Yoo, H.
    Lim, M.
    Seo, S.
    Park, S.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S100 - S100
  • [45] HE4: A NOVEL TUMOR MARKER IN DIFFERENTIAL DIAGNOSTICS OF OVARIAN CANCER
    Granatova, J.
    Borecka, K.
    Tuma, J.
    Bednarova, K.
    Vranova, J.
    Donatova, Z.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S240 - S240
  • [46] A predictive model combining HE4 and ultrasound features for ovarian cancer
    Stiekema, A.
    Lok, C. A. R.
    Kenter, G. G.
    van Driel, W. J.
    Korse, C. M.
    TUMOR BIOLOGY, 2012, 33 : 79 - 79
  • [47] Prognostic significance of serum HE4 in epithelial ovarian cancer.
    Marinaccio, M.
    Mele, E.
    Lorusso, V.
    Larocca, A.
    Pellegrino, C.
    Chiappetta, R.
    Sozzi, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [48] CAN HE4 REPLACE CA 125 AS A BIOMARKER IN OVARIAN CANCER?
    Ranjan, A.
    Dubey, H.
    Tanwar, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A222 - A223
  • [49] Comparison of HE4 with other tumor markers in ovarian cancer diagnostics
    Svobodova, S.
    Kucera, R.
    Topolcan, O.
    Presl, J.
    Fuchsova, J. R.
    Vrzalova
    Rokyta, Z.
    Betincova, L.
    Novotny, Z.
    TUMOR BIOLOGY, 2012, 33 : 89 - 89
  • [50] Does HE4 have a role as biomarker in the recurrence of ovarian cancer?
    Plotti, Francesco
    Capriglione, Stella
    Terranova, Corrado
    Montera, Roberto
    Aloisi, Alessia
    Damiani, Patrizio
    Muzii, Ludovico
    Scaletta, Giuseppe
    Benedetti-Panici, Pierluigi
    Angioli, Roberto
    TUMOR BIOLOGY, 2012, 33 (06) : 2117 - 2123
12345